CCL27 and breast carcinoma: Typical profiles of metastatic breast cancer include CK7+, CK20–, CDX2–, and GATA3+, with the loss of E-cadherin expression specifically supporting an ILC origin.9,10) Moreover, the receptor status may not always be congruent between primary and metastatic sites, further complicating diagnosis and treatment planning.11,12)